Diversify Wealth Management LLC raised its stake in shares of Tempus AI, Inc. (NASDAQ:TEM – Free Report) by 86.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 95,877 shares of the company’s stock after buying an additional 44,396 shares during the quarter. Diversify Wealth Management LLC’s holdings in Tempus AI were worth $4,796,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also recently modified their holdings of TEM. JPL Wealth Management LLC purchased a new position in shares of Tempus AI in the third quarter worth $26,000. Los Angeles Capital Management LLC purchased a new position in Tempus AI during the fourth quarter valued at $27,000. Harvest Fund Management Co. Ltd bought a new stake in Tempus AI in the 3rd quarter valued at $38,000. Whittier Trust Co. increased its holdings in Tempus AI by 190.0% in the 1st quarter. Whittier Trust Co. now owns 870 shares of the company’s stock valued at $41,000 after acquiring an additional 570 shares during the last quarter. Finally, Lodestone Wealth Management LLC purchased a new stake in Tempus AI in the 4th quarter worth $42,000. Institutional investors own 24.22% of the company’s stock.
Wall Street Analysts Forecast Growth
TEM has been the subject of several research reports. HC Wainwright dropped their price objective on shares of Tempus AI from $95.00 to $64.00 and set a “buy” rating for the company in a report on Monday, May 11th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Tempus AI in a report on Wednesday, June 17th. TD Cowen boosted their target price on Tempus AI from $65.00 to $68.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Jefferies Financial Group began coverage on Tempus AI in a research note on Monday, April 13th. They set an “underperform” rating and a $35.00 price target for the company. Finally, Needham & Company LLC restated a “buy” rating and set a $75.00 price target on shares of Tempus AI in a report on Monday, June 1st. Nine investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, Tempus AI presently has an average rating of “Hold” and a consensus target price of $68.54.
Insider Activity
In other Tempus AI news, EVP Andrew Polovin sold 8,703 shares of the business’s stock in a transaction on Tuesday, May 19th. The shares were sold at an average price of $44.07, for a total transaction of $383,541.21. Following the transaction, the executive vice president owned 128,215 shares in the company, valued at $5,650,435.05. The trade was a 6.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Ryan Fukushima sold 33,284 shares of the company’s stock in a transaction dated Wednesday, July 8th. The shares were sold at an average price of $57.39, for a total transaction of $1,910,168.76. Following the transaction, the chief executive officer owned 167,763 shares in the company, valued at $9,627,918.57. The trade was a 16.56% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 616,043 shares of company stock valued at $31,748,593 over the last ninety days. 24.26% of the stock is owned by corporate insiders.
Tempus AI Price Performance
TEM stock opened at $58.23 on Monday. Tempus AI, Inc. has a 52 week low of $41.73 and a 52 week high of $104.32. The firm has a market capitalization of $10.46 billion, a P/E ratio of -33.85 and a beta of 3.46. The company has a fifty day simple moving average of $51.29 and a two-hundred day simple moving average of $54.27. The company has a quick ratio of 3.15, a current ratio of 3.31 and a debt-to-equity ratio of 2.96.
Tempus AI (NASDAQ:TEM – Get Free Report) last posted its earnings results on Tuesday, May 5th. The company reported ($0.13) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.08. Tempus AI had a negative net margin of 22.20% and a negative return on equity of 53.83%. The firm had revenue of $348.12 million for the quarter, compared to the consensus estimate of $345.44 million. During the same period in the previous year, the firm posted ($0.24) EPS. The business’s quarterly revenue was up 36.1% on a year-over-year basis. Analysts anticipate that Tempus AI, Inc. will post -1.35 earnings per share for the current fiscal year.
Tempus AI Company Profile
Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.
The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.
Featured Articles
- Five stocks we like better than Tempus AI
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM – Free Report).
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.
